1025 related articles for article (PubMed ID: 15533354)
21. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
22. Anti-Müllerian hormone concentrations in maternal serum during pregnancy.
La Marca A; Giulini S; Orvieto R; De Leo V; Volpe A
Hum Reprod; 2005 Jun; 20(6):1569-72. PubMed ID: 15734752
[TBL] [Abstract][Full Text] [Related]
23. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels.
Singer T; Barad DH; Weghofer A; Gleicher N
Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223
[TBL] [Abstract][Full Text] [Related]
24. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve.
Hendriks DJ; Broekmans FJ; Bancsi LF; de Jong FH; Looman CW; Te Velde ER
Hum Reprod; 2005 Jan; 20(1):163-9. PubMed ID: 15471926
[TBL] [Abstract][Full Text] [Related]
25. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
[TBL] [Abstract][Full Text] [Related]
26. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
27. Use of serum inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproduction treatment outcome.
Urbancsek J; Hauzman E; Klinga K; Rabe T; Papp Z; Strowitzki T
Fertil Steril; 2005 Feb; 83(2):341-8. PubMed ID: 15705372
[TBL] [Abstract][Full Text] [Related]
28. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.
Smeenk JM; Sweep FC; Zielhuis GA; Kremer JA; Thomas CM; Braat DD
Fertil Steril; 2007 Jan; 87(1):223-6. PubMed ID: 17081531
[TBL] [Abstract][Full Text] [Related]
29. Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation.
La Marca A; Malmusi S; Giulini S; Tamaro LF; Orvieto R; Levratti P; Volpe A
Hum Reprod; 2004 Dec; 19(12):2738-41. PubMed ID: 15459174
[TBL] [Abstract][Full Text] [Related]
30. [Usefulness of inhibin B, serum progesterone, and AMH concentrations obtained during controlled ovarian hyperstimulation (COH) in predicting ovarian response and oocyte quality].
Dewailly D
J Gynecol Obstet Biol Reprod (Paris); 2006 Sep; 35(5 Pt 2):2S44-2S46. PubMed ID: 17057624
[TBL] [Abstract][Full Text] [Related]
31. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
32. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.
Fanchin R; Taieb J; Lozano DH; Ducot B; Frydman R; Bouyer J
Hum Reprod; 2005 Apr; 20(4):923-7. PubMed ID: 15640257
[TBL] [Abstract][Full Text] [Related]
33. Follicle-stimulating hormone and estradiol levels independently predict the success of assisted reproductive technology treatment.
Frazier LM; Grainger DA; Schieve LA; Toner JP
Fertil Steril; 2004 Oct; 82(4):834-40. PubMed ID: 15482756
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
[TBL] [Abstract][Full Text] [Related]
35. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology.
Silberstein T; MacLaughlin DT; Shai I; Trimarchi JR; Lambert-Messerlian G; Seifer DB; Keefe DL; Blazar AS
Hum Reprod; 2006 Jan; 21(1):159-63. PubMed ID: 16123085
[TBL] [Abstract][Full Text] [Related]
36. Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome.
Wang JG; Nakhuda GS; Guarnaccia MM; Sauer MV; Lobo RA
Am J Obstet Gynecol; 2007 Jan; 196(1):77.e1-5. PubMed ID: 17240243
[TBL] [Abstract][Full Text] [Related]
37. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
[TBL] [Abstract][Full Text] [Related]
38. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
[TBL] [Abstract][Full Text] [Related]
39. Relevance of anti-Mullerian hormone measurement in a routine IVF program.
Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E
Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961
[TBL] [Abstract][Full Text] [Related]
40. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
